共 170 条
[1]
Luirink IK(2019)20-year follow-up of statins in children with familial hypercholesterolemia N Engl J Med 381 1547-1556
[2]
Wiegman A(2017)Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults Lancet 390 2627-42
[3]
Kusters DM(2016)Statin-associated side effects J Am Coll Cardiol 67 2395-2410
[4]
Thompson PD(2008)Immortal time bias in pharmaco-epidemiology Am J Epidemiol 167 492-499
[5]
Panza G(2019)Use of genetic variants related to antihypertensive drugs to inform on efficacy and side effects Circulation 140 270-279
[6]
Zaleski A(2020)Evaluating the impact of AMPK activation, a target of metformin, on risk of cardiovascular diseases and cancer in the UK Biobank: a Mendelian randomisation study Diabetologia 63 2349-2358
[7]
Taylor B(2022)Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study BMC Med 20 288-662
[8]
Suissa S(2022)Mendelian randomization study of PCSK9 and HMG-CoA reductase inhibition and cognitive function J Am Coll Cardiol 80 653-1327
[9]
Gill D(2020)Evolocumab in pediatric heterozygous familial hypercholesterolemia N Engl J Med 383 1317-620
[10]
Georgakis MK(2020)Genetic drug target validation using Mendelian randomisation Nat Commun 11 3255-1096